[Federal Register Volume 74, Number 180 (Friday, September 18, 2009)]
[Notices]
[Page 47962]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-22503]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 2, 2009, GE Healthcare, 
3350 North Ridge Avenue, Arlington Heights, Illinois 60004-1412, made 
application by renewal to the Drug Enforcement Administration (DEA) as 
a bulk manufacturer of Cocaine (9041), a basic class of controlled 
substance in schedule II.
    The company plans to manufacture a radioactive product used in 
diagnostic imaging in the diagnosis of Parkinson's Disease and for 
manufacture in bulk for investigational new drug (IND) submission and 
clinical trials.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such a substance, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, VA 22152; and must be filed no later 
than November 17, 2009.

    Dated: September 14, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-22503 Filed 9-17-09; 8:45 am]
BILLING CODE 4410-09-P